Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  Lin, Yingying ^b,c   Qiu, Yongming ^c   Xu, Cheng ^c   Liu, Qiaoling ^a   Peng, Baowei ^a   Kaufmann, Gunnar F ^d,e   Chen, Xi ^b   Lan, Bin ^b   Wei, Chongyang ^a   Lu, Desheng ^g   Zhang, Yueshan ^a   Guo, Yifeng ^c   Lu, Zhimin ^f   Jiang, Biao ^h   Edgington, Thomas S ^d,i   Guo, Fang ^a,b  

^a SHANGHAI ADVANCED RESEARCH INSTITUTE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Sorrento Thearpeutics Inc   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g SHENZHEN UNIVERSITY   (China)

^h SHANGHAITECH UNIVERSITY   (China)

ⁱ Department of Immunology and Microbial Science ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; LEGUMAIN; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; CYSTEINE PROTEINASE; HSP90ALPHA PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER PROGNOSIS; CHEMICAL ANALYSIS; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; UBIQUITINATION; ANIMAL; BREAST TUMOR; DISEASE COURSE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL NEOPLASM; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR MARKERS, BIOLOGICAL; UBIQUITINATION;

EID: 84898858763     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju012     Document Type: Article

References (51)

1. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta. 2000;291(2):113-135.
2. Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 2006;5(9):785-799.
3. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003;4(7):544-558.
4. Joyce JA, Baruch A, Chehade K, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumori-genesis. Cancer Cell. 2004;5(5):443-453.
5. Decock J, Paridaens R, Cufer T. Proteases and metastasis: clinical relevance nowadays? Curr Opin Oncol. 2005;17(6):545-550.
6. Coussens LM, Fingleton B, Matrisian LM. Cancer therapy-matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295(5564):2387-2392.
7. Barrett AJ, Rawlings ND, O'Brien EA. The MEROPS database as a protease information system. J Struct Biol. 2001;134(2-3):95-102.
8. Dando PM, Fortunato M, Smith L, Knight CG, McKendrick JE, Barrett AJ. Pig kidney legumain: an asparaginyl endopeptidase with restricted specificity. Biochem J. 1999;339 (Pt 3):743-749.
9. Biochem J. 1999 May 1;339 (Pt 3):743-9.
10. Miller G, Matthews S P, Reinheckel T, Fleming S, Watts C. Asparagine endopeptidase is required for normal kidney physiology and homeostasis. FASEB J. 2011;25(5):1606-1617.
11. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature. 1998;396(6712):695-699.
12. Liu ZX, Jang SW, Liu X, et al. Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol Cell. 2008;29(6):665-678.
13. Choi SJ, Reddy SV, Devlin RD, et al. Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J Biol Chem. 1999;274(39):27747-27753.
14. Clerin V, Shih HH, Deng N, et al. Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis. Atherosclerosis. 2008;201(1):53-66.
15. Manoury B, Sepulveda FE, Maschalidi S, et al. Critical role for asparagine endopeptidase in endocytic toll-like receptor signaling in dendritic cells. Immunity. 2009;31(5):737-748.
16. Strefford JC, van Delft FW, Robinson HM, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intra-chromosomal amplification of chromosome 21. Proc Natl Acad Sci USA. 2006;103(21):8167-8172.
17. Chen JM, Dando PM, Rawlings ND, et al. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem. 1997;272(12):8090-8098.
18. Liu C, Sun CZ, Huang HN, Janda K, Edgington T. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 2003;63(11):2957-2964.
19. Murthy RV, Arbman G, Gao JF, Roodman GD, Sun XF. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Clin Cancer Res. 2005;11(6):2293-2299.
20. Gawenda J, Traub F, Luck HJ, Kreipe H, von Wasielewski R. Legumain expression as a prognostic factor in breast cancer patients. Breast Cancer Res Treat. 2007;102(1):1-6.
21. Patel N, Krishnan S, Offman MN, et al. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. J Clin Invest. 2009;119(7):1964-1973.
22. Andrade VA, Jardim CA, Melo FM, et al. Nucleoplasmic calcium regulates proliferation of hepatocytes through legumain and reticulon4. Gastroenterology. 2009;136(5):A792-A792.
23. Chen JM, Fortunato M, Stevens RAE, Barrett AJ. Activation of progelati-nase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem. 2001;382(5):777-783.
24. Briggs JJ, Haugen MH, Johansen H T, et al. Cystatin E/M suppresses legumain activity and invasion of human melanoma. BMC Cancer. 2010;10 (17):1-13.
25. Li DN, Matthews S P, Antoniou AN, Mazzeo D, Watts C. Multistep auto-activation of asparaginyl endopeptidase in vitro and in vivo. J Biol Chem. 2003;278(40):38980-38990.
26. Hershko A, Ciechanover A. The ubiquitin system. Ann Rev Biochem. 1998;67:425-479.
27. Hicke L. A new ticket for entry into budding vesicles-ubiquitin. Cell. 2001;106(5):527-530.
28. Deshaies RJ, Joazeiro CAP. RING domain E3 ubiquitin ligases. Ann Rev Biochem. 2009;78:399-434.
29. Pickart CM. Ubiquitin enters the new millennium. Mol Cell. 2001;8(3):499-504.
30. Deng L, Wang C, Spencer E, et al. Activation of the I kappa B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000;103(2):351-361.
31. Sun LJ, Deng L, Ea CK, Xia Z P, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell. 2004;14(3):289-301.
32. Geetha T, Kenchappa RS, Wooten MW, Carter BD. TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. EMBO J. 2005;24(22):3859-3868.
33. Yang WL, Wang J, Chan CH, et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science. 2009;325(5944):1134-1138.
34. Starczynowski DT, Lockwood WW, Delehouzee S, et al. TRAF6 is an amplified oncogene bridging the RAS and NF-kappa B pathways in human lung cancer. J Clin Invest. 2011;121(10):4095-4105.
35. Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899-905.
36. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G. The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review. Pharmacol Ther. 1998;79(2):129-168.
37. Eustace BK, Sakurai T, Stewart JK, et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasive-ness. Nat Cell Biol. 2004;6(6):507-514.
38. Wang XF, Song XM, Zhuo W, et al. The regulatory mechanism of Hsp90 alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci USA. 2009;106(50):21288-21293.
39. Luo YP, Zhou H, Krueger J, et al. Targeting tumor-associated mac-rophages as a novel strategy against breast cancer. J Clin Invest. 2006;116(8):2132- 2141.
40. Mattock KL, Gough PJ, Humphries J, et al. Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis. 2010;208(1):83-89.
41. Ni DTN, Matthews S P, Antoniou AN, Mazzeo D, Watts C. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J Biol Chem. 2003;278(40):38980-38990.
42. Chen JM, Dando PM, Stevens RAE, Fortunato M, Barrett AJ. Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem J. 1998;335 (Pt 1):111-117.
43. Ye H, Arron JR, Lamothe B, et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature. 2002;418(6896):443-447.
44. Lamothe B, Campos AD, Webster WK, Gopinathan A, Hur L, Darnay BG. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J Biol Chem. 2008;283(36):24871- 24880.
45. Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiq-uitinating enzyme interaction landscape. Cell. 2009;138(2):389-403.
46. James KE, Gotz MG, Caffrey CR, et al. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases). Biol Chem. 2003;384(12):1613-1618.
47. Wu BH, Yin J, Texier C, Roussel M, Tan KSW. Blastocystis legumain is localized on the cell surface, and specific inhibition of its activity implicates a pro-survival role for the enzyme. J Biol Chem. 2010;285(3):1790- 1798.
48. Havugimana PC, Hart GT, Nepusz T, et al. A census of human soluble protein complexes. Cell. 2012;150(5):1068-1081.
49. Andrade V, Guerra M, Jardim C, et al. Nucleoplasmic calcium regulates cell proliferation through legumain. J Hepatol. 2011;55(3):626-635.
50. Braulke T, Bonifacino JS. Sorting of lysosomal proteins. Biochim Biophys Acta. 2009;1793(4):605-614.
51. Smith R, Johansen HT, Nilsen H, et al. Intra-and extracellular regulation of activity and processing of legumain by cystatin E/M. Biochimie. 2012;94(12):2590-2599.